Option chain shows key data for NewAmsterdam Pharma Co's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NewAmsterdam Pharma Co.

NewAmsterdam Pharma Co (NASDAQ:NAMSW) Stock, Option Chain

NewAmsterdam Pharma Company N.V. - Warrant

NewAmsterdam Pharma Co

Overview

News

Short Interest

Stock Report

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Comments

NewAmsterdam Pharma Co Option Chain

No option chain data available. Please try again later